NOVEMBER 23, 2020
British drugs group AstraZeneca and the University of Oxford on Monday said their jointly-developed vaccine against Covid-19 has shown “an average efficacy of 70 percent” in trials.
“This vaccine’s efficacy and safety confirm that it will be highly effective against Covid-19 and will have an immediate impact on this public health emergency,” AstraZeneca chief executive Pascal Soriot said in a statement.
AFP reports that the vaccine has produced lower average efficacy compared with coronavirus vaccines produced by rivals Pfizer/BioNTech and Moderna which have come in above 90 percent.
Lawyer Slams Police for Ignoring Court Order in Speed Darlington Case Speed Darlington’s Lawyer Says…
Allen Onyema Warns of Dangerous Campaign Against Air Peace Air Peace CEO Calls for Investigation…
Naira Strengthens to N1,534/$ Post-Christmas Holiday Parallel Market: Naira Closes at N1,650/$ on Friday FX…